Demant
Financials
Estimates*
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.9b | 2.5b | 2.6b | 3.0b | 3.0b | 3.3b | 3.5b |
% growth | (3 %) | 27 % | 7 % | 14 % | 1 % | 8 % | 8 % |
EBITDA | 344m | 605m | 584m | 731m | 783m | 853m | 928m |
% EBITDA margin | 18 % | 25 % | 22 % | 24 % | 26 % | 26 % | 26 % |
Profit | 149m | 335m | 278m | 239m | 356m | 427m | 484m |
% profit margin | 8 % | 14 % | 11 % | 8 % | 12 % | 13 % | 14 % |
EV / revenue | 4.5x | 4.9x | 2.8x | 3.4x | 3.4x | 3.1x | 2.9x |
EV / EBITDA | 25.1x | 19.7x | 12.6x | 13.9x | 12.9x | 11.8x | 10.8x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | N/A | IPO | |
* | €115m | Post IPO Debt | |
* | DKK375m | Post IPO Debt | |
Total Funding | - |
Recent News about Demant
EditDemant operates in the hearing healthcare industry, providing a wide range of products and services including hearing devices, hearing implants, diagnostic instruments, and professional hearing care. The company serves individuals with hearing loss, aiming to improve their quality of life through advanced hearing solutions. Demant's business model is centered around the development, manufacturing, and distribution of hearing healthcare products, generating revenue through the sale of these products and related services. The company leverages synergies across its diverse product portfolio to drive innovation and operational efficiency. Demant operates globally, with a strong presence in both developed and emerging markets. The company's profitability is driven by its core segments: Hearing Aids, Hearing Care, and Diagnostics. Recent financial performance has shown strong results, with an EBIT outlook upgrade driven by robust performance in these key areas. Demant is also committed to sustainability, continuously working to strengthen its operational practices to support sustainable healthcare globally.
Keywords: hearing healthcare, hearing devices, hearing implants, diagnostic instruments, professional care, global market, innovation, sustainability, profitability, operational efficiency.